Edwards Lifesciences Corporation

Edwards Lifesciences Beats on EPS, Stock Down 0.69%

Edwards Lifesciences reported an EPS of $0.58, slightly beating expectations. However, the stock reacted negatively, declining by 0.69%. This could indicate investor concerns despite the earnings beat, possibly due to a lack of revenue data and management guidance.